Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome
Authors:
- 1 May 2005
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 20 (5) , 258-263
Abstract
Aim. This study was designed to examine the relationship between homocysteine (Hcy), lipoprotein levels and insulin resistance in obese and non-obese patients with polycystic ovary syndrome (PCOS). Materials and methods. Eighty-five patients (38 obese, 47 non-obese) with PCOS and 50 healthy subjects (25 obese, 25 non-obese) were included in the study. PCOS was defined according to the Homburg criterion. Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), dehydroepiandrosterone sulfate (DHEA-S), insulin, 17-hydroxyprogesterone, free testosterone, androstenedione, vitamin B12 and folate were measured. Also, serum concentrations of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lp(a)), apoprotein B (Apo B) and apoprotein A (Apo A) were determined. Plasma Hcy levels were measured. Insulin resistance was evaluated by homeostasis model assessment (HOMA). Results. Plasma Hcy levels were significantly higher in women with PCOS than in healthy women. HOMA-R (insulin resistance) was significantly higher in women with PCOS compared with healthy women. Serum fasting TC, LDL-C, TG, Apo B, vitamin B12 and folate levels were similar between PCOS and control groups. Lp(a) levels were higher in PCOS patients than in control subjects, whereas HDL-C and Apo A levels were lower. Compared with obese PCOS subjects, non-obese PCOS subjects had low HOMA-R, TC, LDL-C, TG, Apo B, Lp(a) and androgen levels. Plasma Hcy levels, serum HDL-C and Apo A levels were similar between obese and non-obese women with PCOS. Levels of HDL-C and Apo A were lower in both obese and non-obese PCOS patients than in obese and non-obese control subjects, whereas Lp(a) levels were higher. No correlation was observed between plasma Hcy, body mass index, HOMA-R, serum androgen levels, TC, LDL-C, HDL-C, Apo A, Apo B and Lp(a) levels. Conclusion. These results showed that elevated insulin resistance and plasma Hcy levels, and changes in serum lipid profile, which are possible risk factors for cardiovascular disorders, play important roles in the development of cardiovascular disease in both obese and non-obese patients with PCOS.Keywords
This publication has 16 references indexed in Scilit:
- Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?Clinical Endocrinology, 2004
- Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?Endocrine Reviews, 2003
- What is polycystic ovarian syndrome?: A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndromeHuman Reproduction, 2002
- The Plasma Homocysteine Levels Are Increased in Polycystic Ovary SyndromeGynecologic and Obstetric Investigation, 2002
- Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort studyClinical Endocrinology, 2000
- Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1998
- Adverse Lipid and Coronary Heart Disease Risk Profiles in Young Women with Polycystic Ovary Syndrome: Results of a Case-Control StudyJournal of Clinical Epidemiology, 1998
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998
- Cardiovascular Risk in Women With Polycystic Ovarian SyndromeSeminars in Reproductive Medicine, 1996
- Polycystic Ovary SyndromeNew England Journal of Medicine, 1995